Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
20 participants
INTERVENTIONAL
2021-02-23
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The aim of the study is to investigate the effects of reducing dietary protein (\~1g protein/kg body mass) compared to an eucaloric normal protein diet (\~2g protein/kg body mass) for 6 weeks in well-trained endurance athletes on endurance performance, body composition, skeletal muscle protein synthesis, and health-related outcomes.
The hypothesis is that endurance performance will maintain or even be improved in well-trained endurance athletes after a 6-week dietary intervention of an eucaloric, protein reduced diet compared to a normal protein rich diet.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Protein Intake and Exercise-induced Muscle Damage
NCT06235476
Protein Requirements in Male and Female Endurance Athletes
NCT04855474
Protein Intake and Physical Performance
NCT02594228
Manipulation of Dietary Protein and the Anabolic Response
NCT01820975
Protein Supplementation and Endurance Exercise Adaptations
NCT03462381
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Subjects and dietary goals: The study is aiming at including 20 male endurance athletes exercising \~15hrs+/week. The 20 males will be pair-matched based on habitual endurance training, habitual dietary protein intake, and endurance performance, and allocated in a randomised order to: 1) a reduced-protein diet (RP) or 2) a normal-protein diet (NP).
3-weeks run-in period: After a minimum of 7 days after written consent has been obtained, the run-in period will begin. Habitual endurance training volumes will be registered in an online platform (TrainingPeaks) and daily activity level will be monitored using an accelerometer (SENS) throughout the run-in and diet intervention period. "Heavy water" (D2O) will be ingested in a large bolus (3.5ml/kg LBM) upon beginning of the run-in period and plasma enrichments will be maintained throughout the study period by ingesting small daily boluses. This serves to determine skeletal muscle protein synthesis throughout the study.
6-weeks dietary intervention: The diets will be eucaloric and the estimated energy percentages for macronutrients will be as follows: RP - Protein \~7E%, Carbohydrate \~63E%, Fat \~29E%. NP - Protein \~16E%, Carbohydrate \~53E%, Fat \~30E%. Weekly urine and faeces samples will be collected during the run-in period and dietary intervention and the controlled diets will be supplied weekly for the participants.
Testing: Extensive endurance performance and metabolic testing will be performed prior to-, and during the intervention on weeks -1, 0 (Pre), 3 (Mid), and 6 (Post). The tests include: Body composition by DXA-scanning, resting metabolic rate by online respirometry using a Vyntus (Jaeger, PCX), venous blood-, and skeletal muscle biopsy sampling from m. Vastus Lateralis, a standardised breakfasts, endurance cycling on an electro-magnetically braked bike (Lode Excalibur) or running on a motorised treadmill (Woodway), and haemoglobin mass measuring using a modified version of the CO-rebreathing method.
The body mass will be kept unchanged during the 6-weeks dietary intervention.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Reduced protein diet
A 6-week eucaloric dietary intervention of reduced protein intake (\~1g protein/kg body mass). The diet will, hence, contain \~7E% protein, \~63E% carbohydrate, and \~29E% fat.
Participants are free-living and receive all food pre-packed from the study kitchen. The energy provision will be set to match energy balance.
Dietary intervention of reduced protein intake
6-wk dietary intervention of reduced protein intake
Normal protein diet
A 6-week eucaloric dietary intervention of normal protein intake (\~2g protein/kg body mass). The diet will, hence, contain \~16E% protein, \~53E% carbohydrate, and \~30E% fat.
Participants are free-living and receive all food pre-packed from the study kitchen. The energy provision will be set to match energy balance.
Dietary intervention of normal protein intake
6-wk dietary intervention of normal protein intake
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dietary intervention of reduced protein intake
6-wk dietary intervention of reduced protein intake
Dietary intervention of normal protein intake
6-wk dietary intervention of normal protein intake
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Exercising at least 10hrs per week
* Habitual dietary protein intake \~2g/kg body mass
* BMI\<25
Exclusion Criteria
* Inconsistent endurance training load
20 Years
50 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Maastricht University Medical Center
OTHER
University of Copenhagen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Bente Kiens
Professor of Exercise, Nutrition and Metabolism, D Sci, PhD, Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nicki W Almquist, Post Doc
Role: STUDY_DIRECTOR
University of Copenhagen
Bente Kiens, Professor
Role: PRINCIPAL_INVESTIGATOR
University of Copenhagen
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Copenhagen
Copenhagen, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PROPER
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.